PLGA nanoparticles improve the oral bioavailability of curcumin in rats: Characterizations and mechanisms

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 17, 2011, Pages 9280-9289

  Xie, Xiaoxia ^a   Tao, Qing ^a   Zou, Yina ^a   Zhang, Fengyi ^a   Guo, Miao ^a   Wang, Ying ^a   Wang, Hui ^a   Zhou, Qian ^a   Yu, Shuqin ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

bioavailability; curcumin; intestinal permeability; nanoparticles; P gp efflux; PLGA

Indexed keywords

BIOAVAILABILITY; CURCUMIN; INTESTINAL PERMEABILITY; P-GP EFFLUX; PLGA;

CONTROLLED DRUG DELIVERY; GLYCOPROTEINS; NANOPARTICLES; SOLUBILITY; WATER ABSORPTION;

BIOCHEMISTRY;

CURCUMIN; DRUG CARRIER; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL; ARTICLE; BIOAVAILABILITY; CHEMISTRY; INTESTINE ABSORPTION; MALE; MICROCAPSULE; PARTICLE SIZE; RAT; SOLUBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; CAPSULES; CURCUMIN; DRUG CARRIERS; INTESTINAL ABSORPTION; LACTIC ACID; MALE; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

RATTUS;

EID: 80052594404     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf202135j     Document Type: Article

References (39)

1. Sharma, R. A.; Gescher, A. J.; Steward, W. P. Curcumin: the story so far Eur. J. Cancer 2005, 41 (13) 1955-1968 (Pubitemid 41557681)
2. Negi, P. S.; Jayaprakasha, G. K.; Jagan Mohan Rao, L.; Sakariah, K. K. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture J. Agric. Food Chem. 1999, 47 (10) 4297-4300 (Pubitemid 29506239)
3. Zhou, H.; Beevers, C. S.; Huang, S. The targets of curcumin Curr. Drug Targets 2011, 12 (3) 332-347
4. Yen, F.-L.; Wu, T.-H.; Tzeng, C.-W.; Lin, L.-T.; Lin, C.-C. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities J. Agric. Food Chem. 2010, 58 (12) 7376-7382
5. Shehzad, A.; Wahid, F.; Lee, Y. S. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials Arch. Pharm. (Weinheim) 2010, 343 (9) 489-499
6. Aggarwal, B. B.; Kumar, A.; Bharti, A. C. Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res. 2003, 23 (1A) 363-398 (Pubitemid 36361976)
7. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Bioavailability of curcumin: problems and promises Mol. Pharmaceutics 2007, 4 (6) 807-818
8. Bhawana; Basniwal, R. K.; Buttar, H. S.; Jain, V. K.; Jain, N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study J. Agric. Food Chem. 2011, 59 (5) 2056-2061
9. Takahashi, M.; Uechi, S.; Takara, K.; Asikin, Y.; Wada, K. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin J. Agric. Food Chem. 2009, 57 (19) 9141-9146
10. Kakkar, V.; Singh, S.; Singla, D.; Kaur, I. P. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin Mol. Nutr. Food Res. 2011, 55 (3) 495-503
11. Marcolino, V. A.; Zanin, G. M.; Durrant, L. R.; de Toledo Benassi, M.; Matioli, G. Interaction of curcumin and bixin with β-cyclodextrin: complexation methods, stability, and applications in food J. Agric. Food Chem. 2011, 59 (7) 3348-3357
12. Ghosh, M.; Singh, A. T.; Xu, W.; Sulchek, T.; Gordon, L. I.; Ryan, R. O. Curcumin nanodisks: formulation and characterization Nanomedicine 2011, 7 (2) 162-167
13. Johnson, B. M.; Charman, W. N.; Porter, C. J. The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamil J. Pharm. Pharmacol. 2001, 53 (12) 1611-1619 (Pubitemid 34044249)
14. Mach, C. M.; Chen, J. H.; Mosley, S. A.; Kurzrock, R.; Smith, J. A. Evaluation of liposomal curcumin cytochrome p450 metabolism Anticancer Res. 2010, 30 (3) 811-814
15. Wahlang, B.; Pawar, Y. B.; Bansal, A. K. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model Eur. J. Pharm. Biopharm. 2011, 77 (2) 275-282
16. Astete, C. E.; Sabliov, C. M. Synthesis and characterization of PLGA nanoparticles J. Biomater. Sci. Polym. Ed. 2006, 17 (3) 247-289 (Pubitemid 47279194)
17. Fonseca, C.; Simoes, S.; Gaspar, R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity J. Controlled Release 2002, 83 (2) 273-286 (Pubitemid 35282471)
18. Yadav, A. K.; Mishra, P.; Mishra, A. K.; Jain, S.; Agrawal, G. P. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin Nanomedicine 2007, 3 (4) 246-257 (Pubitemid 350199644)
19. Cartiera, M. S.; Ferreira, E. C.; Caputo, C.; Egan, M. E.; Caplan, M. J.; Saltzman, W. M. Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin Mol. Pharmaceutics 2010, 7 (1) 86-93
20. Mukerjee, A.; Vishwanatha, J. K. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy Anticancer Res. 2009, 29 (10) 3867-3875
21. Anand, P.; Nair, H. B.; Sung, B.; Kunnumakkara, A. B.; Yadav, V. R.; Tekmal, R. R.; Aggarwal, B. B. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo Biochem. Pharmacol. 2010, 79 (3) 330-338
22. Varma, M. V.; Sarkar, M.; Kapoor, N.; Panchagnula, R. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs 1. Simultaneous determination of quinidine and permeability markers in rat in situ perfusion samples J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2005, 816 (1-2) 243-249 (Pubitemid 40143512)
23. Komiya, I.; Park, J. Y.; Kamani, A.; Ho, N. F. H.; Higuchi, W. I. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes Int. J. Pharm. 1980, 4 (3) 249-262 (Pubitemid 10114888)
24. Wischke, C.; Schwendeman, S. P. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles Int. J. Pharm. 2008, 364 (2) 298-327
25. Manju, S.; Sreenivasan, K. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability J. Colloid Interface Sci. 2011, 359 (1) 318-325
26. Mohanty, C.; Sahoo, S. K. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 2010, 31 (25) 6597-6611
27. Yang, K. Y.; Lin, L. C.; Tseng, T. Y.; Wang, S. C.; Tsai, T. H. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007, 853 (1-2) 183-189
28. Shaikh, J.; Ankola, D. D.; Beniwal, V.; Singh, D.; Kumar, M. N. V. R. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur. J. Pharm. Sci. 2009, 37 (3-4) 223-230
29. Sasaki, H.; Sunagawa, Y.; Takahashi, K.; Imaizumi, A.; Fukuda, H.; Hashimoto, T.; Wada, H.; Katanasaka, Y.; Kakeya, H.; Fujita, M.; Hasegawa, K.; Morimoto, T. Innovative preparation of curcumin for improved oral bioavailability Biol. Pharm. Bull. 2011, 34 (5) 660-665
30. Tsai, Y.-M.; Jan, W.-C.; Chien, C.-F.; Lee, W.-C.; Lin, L.-C.; Tsai, T.-H. Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats Food Chem. 2011, 127 (3) 918-925
31. Ling, G.; Zhang, P.; Zhang, W.; Sun, J.; Meng, X.; Qin, Y.; Deng, Y.; He, Z. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition J. Controlled Release 2010, 148 (2) 241-248
32. Vasconcelos, T.; Sarmento, B.; Costa, P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov. Today 2007, 12 (23-24) 1068-1075 (Pubitemid 350186132)
33. Bansal, T.; Mishra, G.; Jaggi, M.; Khar, R. K.; Talegaonkar, S. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats Eur. J. Pharm. Sci. 2009, 36 (4-5) 580-590
34. Constantinides, P. P.; Wasan, K. M. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies J. Pharm. Sci. 2007, 96 (2) 235-248 (Pubitemid 46363554)
35. Collnot, E. M.; Baldes, C.; Schaefer, U. F.; Edgar, K. J.; Wempe, M. F.; Lehr, C. M. Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access Mol. Pharmaceutics 2010, 7 (3) 642-651
36. Shono, Y.; Nishihara, H.; Matsuda, Y.; Furukawa, S.; Okada, N.; Fujita, T.; Yamamoto, A. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes J. Pharm. Sci. 2004, 93 (4) 877-885 (Pubitemid 38420399)
37. Tilloy, S.; Monnaert, V.; Fenart, L.; Bricout, H.; Cecchelli, R.; Monflier, E. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier Bioorg. Med. Chem. Lett. 2006, 16 (8) 2154-2157 (Pubitemid 43351069)
38. Mo, R.; Jin, X.; Li, N.; Ju, C.; Sun, M.; Zhang, C.; Ping, Q. The mechanism of enhancement on oral absorption of paclitaxel by N -octyl- O -sulfate chitosan micelles Biomaterials 2011, 32 (20) 4609-4620
39. Jiang, H. L.; Zhu, K. J. Bioadhesive fluorescent microspheres as visible carriers for local delivery of drugs. I: preparation and characterization of insulin-loaded PCEFB/PLGA microspheres J. Microencapsul. 2002, 19 (4) 451-461